Bacteremia due to quinolone-resistant Escherichia coli in a teaching hospital in South Korea

Clinical Infectious Diseases

Volumn 33, Issue 1, 2001, Pages 48-53

  Cheong, H J ^a   Yoo, C W ^a   Sohn, J W ^a   Kim, W J ^a   Kim, M J ^a   Park, S C ^a  

^a Korea University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; BACTERIUM ISOLATE; CONTROLLED STUDY; ESCHERICHIA COLI; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; NATURAL SELECTION; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; RISK FACTOR; SCORING SYSTEM; SOUTH KOREA;

ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; BACTEREMIA; CIPROFLOXACIN; DRUG RESISTANCE, MICROBIAL; DRUG RESISTANCE, MULTIPLE; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; HOSPITALS, TEACHING; HUMANS; INCIDENCE; KOREA; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; RISK FACTORS;

EID: 0034987891     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/320873     Document Type: Article

References (25)

1. Norfloxacin, ciprofloxacin, and ofloxacin: Current clinical roles
2. Ciprofloxacin anal the fluoroquinolone: New concepts on the mechanism of action and resistance
3. Emerging resistance to fluoroquinolones in staphylococci: An alert
4. Clinical isolate of Citrobacter freundii highly resistant to new quinolones
5. The emergence of ciprofloxacin resistance in Salmonella typhimurium
6. Isolation of fluoroquinolone-resistant Escherichia coli and Klebsiella pneumoniae from an infected Hickman catheter
7. Quinolone resistance in clinical isolates of Serratia marcescens
8. Infection prophylaxis in neutropenic patients with acute leukemia: A randomized comparative study with ofloxacin, ciprofloxacin and co-trimoxazole/colistin
9. Caomparison of ciprofloxacin, ofloxacin and pefloxacin for the prevention of the bacterial infection in neutropenic patients with haematological malignancies
10. Infection prophylaxis in acute leukemia: A comparison of ciprofloxacin with trimethoprim-sulfamethoxazole and colistin
11. Prevention of bacterial infection in neutropenic patients with hematologic malignancies: A randomized, multicenter trial comparing norfloxacin with ciprofloxacin
12. Ofloxacin versus trimethoprim-sulfamethoxazole for prevention of infection in patients with acute leukemia and granulocytopenia
13. Prophylaxis of bacterial infections with ciprofloxacin in patients undergoing bone marrow transplantation
14. Rapid emergence of quinolone resistance in cirrhotic patients treated with norfloxacin to prevent spontaneous bacterial peritonitis
15. Relationship between quinolone use and emergence of ciprofloxacin-resistant E. coli in bloodstream infections
16. Emergence of ciprofloxacin resistance in E. coli isolates after widespread use of fluoroquinolones
17. Antimicrobial use and resistance in eight US hospitals: Complexities of analysis and modeling
18. PA, National Committee for Clinical Laboratory Standards (NCCLS) Performance standards for antimicrobial susceptibility testing 9th international supplement NCCLS document M100-S9 Villanova, National Committee for Clinical Laboratory Standards
19. Comparative antimicrobial resistance and genomic diversity of E. coli isolated from urinary tract infections in the community and in hospital
20. The emergence of highly fluoroquinolone-resistant E. coli in community-acquired urinary tract infections
21. Ten-year survey of quinolone resistance in Escherichia coli causing urinary tract infections
22. Mechanisms of resistance to quinolones
23. Use of a broad-host-range gyrA plasmid for genetic characterization of fluoroquinolone-resistant gram-negative bacteria
24. Mutation in the gyrA gene of a highly fluoroquinolone-resistant clinical isolate of E. coli
25. A novel, double mutation in DNA gyrase A of E. coli conferring resistance to quinolone antibiotics